Nephro Care India logo

Nephro Care India financials and balance sheet

NSE: NEPHROCAREHealthcare Services

Last close ₹83.00down ₹2.95 (3.43%)

Share price at the NSE close on 23 Oct 2026. Previous close ₹85.95.

52-week range of traded prices to 23 Oct 2026
₹50.05Low, 30 Mar 2026₹156.35High, 18 Nov 2025
Market cap
₹137 Cr
P/E
No recent results
P/B
No recent results
Dividend yield
Nonein the last 12 months
Volume, NSE
19,20081.3% delivered

3 years at a glance

Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to March.Nephro Care India annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
Peak revenue ₹89 Cr, year to Mar 2026

Operating and net margin, per cent

  • Operating margin
  • Net margin

Results for the year to Mar 2026

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue89
  2. Materials and goods−26
  3. Employee costs−15
  4. Other expenses−39
  5. Operating profit8.3
  6. Depreciation−5.1
  7. Other income+1.5
  8. Finance costs−0.2
  9. Profit before tax4.6
  10. Tax−1.3
  11. Net profit3.4

What the company owns

  • Plant, investments and other assets₹48 Cr
  • Current investments₹10 Cr
  • Cash and bank₹6 Cr
  • Receivables₹6 Cr
  • Inventory₹2 Cr

What pays for it: net worth and liabilities

  • Net worth₹57 Cr
  • Other liabilities₹9 Cr
  • Owed to suppliers₹7 Cr

Profit and loss

Standalone, ₹ crore, years to March.Nephro Care India quarterly results

₹ croreMar 2024Mar 2025Filed 28 MayMar 2026Filed 10 Jul
Revenue from operations27.246.088.7
20.840.280.4
Materials and goods bought9.113.126.4
Employee costs2.27.614.8
Other expenses9.519.539.2
Operating profit before depreciation6.55.98.3
Operating margin23.7%12.8%9.4%
Materials, % of revenue33.4%28.4%29.7%
Employee costs, % of revenue7.9%16.5%16.7%
Other expenses, % of revenue35.0%42.4%44.2%
Depreciation and amortisation0.52.55.1
Operating profit after depreciation5.93.43.2
Other income0.41.51.5
Finance costs0.10.10.2
One-off items0.0––
Profit before tax6.24.84.6
–1.21.3
Net profit4.43.63.4
Net margin16.2%7.9%3.8%
Tax is left blank for the year to Mar 2024: profit before tax less the tax charge stated does not come to the profit after tax the same statement states, so the tax charge is not shown.

Balance sheet

Standalone, ₹ crore, at 31 March.

₹ croreMar 2025Filed 28 MayMar 2026Filed 10 Jul
53.556.9
Share capital16.516.5
Reserves37.040.4
Borrowings0.00.0
14.015.3
0.80.5
Total assets68.372.7
40.042.0
28.230.7
Net debt−20.7−16.4
Borrowings are counted again inside the liabilities due within a year and after a year. No balance sheet is on record for the year to Mar 2024, so its lines and the ratios worked from it are blank there.

Cash flow

Standalone, ₹ crore, years to March.

₹ croreMar 2025Filed 28 MayMar 2026Filed 10 Jul
7.02.2
9.24.0
3.1−5.4
Receivables−3.1−2.8
Inventories−0.9−1.1
Payables2.02.9
Other working capital5.1−4.4
Tax paid−1.2−1.8
Capital spending29.27.7
Free cash flow−22.2−5.5
−39.6−0.5
Cash from financing36.00.0
Dividends paid0.00.0
Shares issued4.60.0
Net change in cash3.41.7
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only. No cash flow statement is on record for the year to Mar 2024.

Per share

Standalone, ₹ per share, years to March.

₹ per shareMar 2025Filed 28 MayMar 2026Filed 10 Jul
Earnings per share₹2.38₹2.04
Diluted earnings per share₹2.38₹2.04
Book value per share₹32.44₹34.49
Shareholder yield−2.2%0.0%
Market cap at the year end (₹ crore)21085

Ratios

Standalone, years to March.Nephro Care India PE ratio and valuation

RatioMar 2024Mar 2025Filed 28 MayMar 2026Filed 10 Jul
Revenue growth–69.0%92.8%
Operating profit growth–−9.2%41.7%
Net profit growth–−17.5%−7.4%
Earnings per share growth––−14.3%
–6.8%6.1%
––−0.7 pts
From the net margin––−3.5 pts
From asset turnover––2.8 pts
From borrowing––0.0 pts
Return on capital employed–6.4%5.7%
Cash conversion–191.4%65.6%
Interest cover69.831.020.5
Debt to equity–0.000.00
Receivable days–2625
Inventory days–3432
Payable days–10793
Cash conversion cycle, days–−47−36
Working capital days–−51−4
Asset turnover–0.671.26
Assets per rupee of net worth–1.281.28
Sales per rupee of plant–1.462.61
Capital spending to depreciation–11.871.52
No balance sheet is on record for the year to Mar 2024, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2026.

Return on assets, latest year
4.8%
Cash from operations against operating profit
26.6%
Measure3 years
Return on equity, average6.5%
Return on capital employed, average6.0%
Operating margin, average15.3%
Net margin, average9.3%
Asset turnover, average0.97
Cash conversion cycle, days, average−42
Interest cover, average40.4
Debt to equity, average0.00

Where the cash came from and went

Standalone: the listed company alone, without its subsidiaries. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ croreLatest year
Cash from operations2.21
Cash from investing−0.48
Cash from financing0.00
Capital spending7.69
Dividends paid0.00
Shares issued for cash0.00
Borrowings raised0.00
Borrowings repaid0.00

Accounting checks

Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2024Mar 2025Mar 2026
Receivables growth less revenue growthOur threshold 0 percentage points––−5.45
Inventory growth less cost-of-goods growthOur threshold 0 percentage points––−15.33
Other current assets growth less revenue growthOur threshold 5 per cent of revenue––3.18
Effective tax ratePublished threshold 17.16 per cent27.6524.65–
Tax charged less tax paid, % of profitOur threshold 10 percentage points–−1.12–
A threshold marked as ours has no published figure; it is the line we read the check against.